Skip to content
Entero Healthcare Solutions logo

Entero Healthcare Solutions IPO

MainboardListedPharma & Healthcare
Check allotment status
Issue price
₹1,258
Listing price
₹1,228.7
-2.33%
Current price
₹1,968.7
+56.49%
Subscribed
1.56x
Issue size
₹1,600 Cr
Listed on
16 Feb 2024

IPO timeline

  1. Opens
    9 FebFri
  2. Closes
    13 FebTue
  3. Allotment
    14 FebWed
  4. Refunds
    15 FebThu
  5. Demat credit
    15 FebThu
  6. Listing
    16 FebFri

Issue details

Price band
₹1,195 – ₹1,258 per share
Issue size
₹1,600 Cr
Fresh issue
Not available
Offer for sale
Not available
Issue type
Fresh capital cum OFS
Face value
₹10 per share
Lot size
11 shares
Minimum investment
₹13,838
Listing on
BSE, NSE
Exchange code
ENTERO · 544122

This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)111₹13,838
Retail (Max)14154₹1,93,732
S-HNI (Min)15165₹2,07,570
B-HNI (Min)73803₹10,10,174

Reservation

QIB
94,91,256 shares (75.00% of the Offer)
NII
18,98,251 shares (15.00% of the Offer)
Retail
12,65,500 shares (10.00% of the Offer)
Employee
70,237 shares (0.55% of the Offer)

Allotment status

Registrar: MUFG Intime India Private Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on MUFG Intime India
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
14 Feb 2024
Refunds initiated
15 Feb 2024
Shares credited to demat
15 Feb 2024
Listing
16 Feb 2024

Grey market premium (GMP)

Updated 13 Feb 2024, 12:00 PM IST
Current GMP
₹15
+1.00%
Estimated listing price
₹1,273
Issue price ₹1,258
Highest
₹120
8 Feb
Lowest
₹15
13 Feb

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
13 Feb 2024₹15+1.00%₹1,273
12 Feb 2024₹25+2.00%₹1,283
10 Feb 2024₹70+6.00%₹1,328
9 Feb 2024₹110+9.00%₹1,368
8 Feb 2024₹120+10.00%₹1,378
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 10 Nov 2026, 06:44 AM IST
Overall subscription
1.56x
Fully subscribed
  • QIB2.29x
  • NII (HNI)0.22x
  • Retail1.38x
  • Employee1.33x

Financials

Amounts in Rs. Crore
P/E Ratio
129.75
EPS (₹)
9.70
RoE
-2.66%
RoCE
6.06%
RoNW
-1.86%
PAT Margin
4.69%
Debt / Equity
0.45
NAV (₹)
174.21

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Period ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets1,505.951,308.731,125.98833.79
Total Income1,898.983,305.722,526.551,783.67
Profit After Tax11.64-11.10-29.44-15.35
NET Worth660.54597.66563.22487.06
Total Borrowing488.68373.52285.03141.70
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Entero Healthcare Solutions
This IPO
₹1,600 Cr129.75-1.86%4.69%1.56x-2.33%
Symbiotec Pharmalab
Mainboard · listed 1 Sep 2026
₹1,757 Cr56.819.48%12.60%71.26x0.00%
Paras Healthcare
Mainboard · listed 28 Oct 2026
₹1,450 Cr37.7211.83%10.38%2.23x+3.90%
Indegene
Mainboard · listed 13 May 2024
₹1,841.76 Cr33.5318.23%12.62%70.3x+44.91%
Akums Drugs & Pharmaceuticals
Mainboard · listed 6 Aug 2024
₹1,856.74 Cr13580-0.57%0.02%63.44x+6.77%
Rubicon Research
Mainboard · listed 16 Oct 2025
₹1,378 Cr46.1329.02%10.37%109.32x+27.84%
Sagility India
Mainboard · listed 12 Nov 2024
₹2,106.4 Cr61.520.29%11.83%3.2x+3.53%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹951.2 Cr total

How Entero Healthcare Solutions plans to use the money raised, as stated in the offer document.

  1. Repayment/prepayment, in full or part, of certain borrowings availed of by our Company₹142.5 Cr
  2. Funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026₹480 Cr
  3. General corporate purposes₹91.7 Cr
  4. Pursuing inorganic growth initiatives through acquisitions₹237 Cr

About Entero Healthcare Solutions

Entero Healthcare Solutions Limited was incorporated in 2018 with its registered office in Gurgaon, Haryana. As per CRISIL, it is among the top three healthcare products distributors in India by revenue in Financial Year 2022. As per CRISIL, it also achieved the fastest scale-up among Indian healthcare products distributors, reaching Rs 25,000 million of operating income within four years of operations. Its technology-driven platform distributes healthcare products to pharmacies, hospitals and clinics across India. Its promoters are Prabhat Agrawal, Prem Sethi and OrbiMed Asia III Mauritius. The IPO was Rs 1,600 crore, with Rs 1,000.07 crore of fresh issue and Rs 599.93 crore of offer for sale by the promoters and other shareholders. Rs 480.00 crore was planned for working capital, Rs 237.00 crore for acquisitions and Rs 142.50 crore for repaying borrowings.

Strengths

  • Total income rose from Rs 1,783.67 crore in FY2021 to Rs 3,305.72 crore in FY2023.
  • It turned a profit of Rs 11.64 crore in the six months to 30 September 2023.
  • Rs 1,000.07 crore of the issue was fresh capital for working capital, acquisitions and debt.
  • It is among the top 3 healthcare products distributors in India by revenue.
  • Net worth grew from Rs 487.06 crore on 31 March 2021 to Rs 660.54 crore on 30 September 2023.

Risks

  • The company made losses of Rs 15.35 crore in FY2021, Rs 29.44 crore in FY2022 and Rs 11.10 crore in FY2023.
  • With a loss in FY2023, the pre-issue P/E was negative, and the market value at Rs 1,258 was about Rs 5,471.40 crore.
  • Distribution margins are thin, and growth needs heavy working capital, with Rs 480.00 crore of the issue planned for it.
  • Total borrowing rose from Rs 141.70 crore on 31 March 2021 to Rs 488.68 crore on 30 September 2023.
  • Promoters held 77.11% before the issue and 52.43% after it.

Promoters and shareholding

Prabhat Agrawal, Prem Sethi and OrbiMed Asia III Mauritius Ltd

Promoter holding, pre-issue
77.11%
Promoter holding, post-issue
52.43%

Anchor investors

25 investors · ₹716.38 Cr raised
InvestorShares allottedAmount% of anchor book
SMALLCAP WORLD FUND, INC13,20,374₹166.1 Cr23.19%
GOVERNMENT OF SINGAPORE11,80,058₹148.45 Cr20.72%
MONETARY AUTHORITY OF SINGAPORE1,45,068₹18.25 Cr2.55%
PIONEER INVESTMENT FUND SCHEME II3,41,814₹43 Cr6%
MIRAE ASSET INDIA SECTOR LEADER EQUITY FUND1,82,831₹23 Cr3.21%
MIRAE ASSET INDIA BLUE CHIP EQUITY MASTER INVESTMENT TRUST79,497₹10 Cr1.4%
CARMIGNAC PORTFOLIO3,37,843₹42.5 Cr5.93%
TT EMERGING MARKETS UNCONSTRAINED FUND1,27,380₹16.02 Cr2.24%
CLSA GLOBAL MARKETS PTE. LTD- ODI2,14,434₹26.98 Cr3.77%
ALLIANZ GLOBAL INVESTORS FUND- ALLIANZ ASIAN MULTI INCOME PLUS2,38,084₹29.95 Cr4.18%
AMUNDI FUNDS NEW SILK ROAD1,86,472₹23.46 Cr3.27%
AMUNDI FUNDS ASIA EQUITY CONCENTRATED51,612₹6.49 Cr0.91%
JUPITER INDIA FUND2,37,743₹29.91 Cr4.17%
THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT72,281₹9.09 Cr1.27%
SBI GENERAL INSURANCE COMPANY LIMITED1,58,994₹20 Cr2.79%
PRIVATE CLIENT EMERGING MARKETS PORTFOLIO79,497₹10 Cr1.4%
NVIT EMERGING MARKETS FUND79,497₹10 Cr1.4%
BARCLAYS MULTI-MANAGER FUND PLC79,090₹9.95 Cr1.39%
MAGNA UMBRELLA FUND PLC - MAGNA EM INCOME AND GROWTH FUND1,58,983₹20 Cr2.79%
BAJAJ ALLIANZ LIFE INSURANCE COMPANY LTD.1,19,240₹15 Cr2.09%
UNIVERSAL SOMPO GENERAL INSURANCE COMPANY LIMITED39,754₹5 Cr0.7%
SOCIETE GENERALE - ODI1,10,841₹13.94 Cr1.95%
MORGAN STANLEY ASIA (SINGAPORE) PTE. - ODI73,858₹9.29 Cr1.3%
GOLDMAN SACHS (SINGAPORE) PTE. - ODI39,754₹5 Cr0.7%
COPTHALL MAURITIUS INVESTMENT LIMITED - ODI ACCOUNT39,754₹5 Cr0.7%

Registrar, lead managers and documents

Entero Healthcare Solutions IPO: common questions

1.When does the Entero Healthcare Solutions IPO open and close?

The Entero Healthcare Solutions IPO opens on 9 Feb 2024 and closes on 13 Feb 2024.

2.What is the price band of the Entero Healthcare Solutions IPO?

The price band is ₹1,195 – ₹1,258 per share, with a lot size of 11 shares and a minimum investment of ₹13,838.

3.What is the size of the Entero Healthcare Solutions IPO?

The issue size is ₹1,600 Cr (Fresh capital cum OFS).

4.What is the GMP of the Entero Healthcare Solutions IPO?

The last reported grey market premium is ₹15 per share as of 13 Feb 2024, 12:00 PM IST. GMP is unofficial and changes frequently.

5.When is the Entero Healthcare Solutions IPO allotment?

The basis of allotment is expected on 14 Feb 2024. Allotment status can be checked with the registrar, MUFG Intime India Private Limited.

6.When will the Entero Healthcare Solutions IPO list?

The shares listed on 16 Feb 2024 on BSE, NSE.

7.Who is the lead manager of the Entero Healthcare Solutions IPO?

The book running lead managers are JM Financial Ltd., SBI Capital Markets Ltd., ICICI Securities, Jefferies India Private Limited, Dam Capital Advisors Ltd, and the registrar is MUFG Intime India Private Limited.

8.What will the money raised in the Entero Healthcare Solutions IPO be used for?

As stated in the offer document, the proceeds are for: Repayment/prepayment, in full or part, of certain borrowings availed of by our Company; Funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026; General corporate purposes; Pursuing inorganic growth initiatives through acquisitions.

9.How can my company launch an IPO like Entero Healthcare Solutions?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393